Age (years) |
66 ± 13 |
66 ± 13 |
0.84 |
Body surface area (m2) |
1.8 ± 0.2 |
2.0 ± 0.2 |
<0.0001 |
Heart rate (b.p.m.) |
72 ± 15 |
70 ± 16 |
0.02 |
Chronic obstructive pulmonary disease, n (%) |
45 (9) |
52 (15) |
0.005 |
Heart failure preserved ejection fraction, n (%) |
306 (62) |
136 (40) |
<0.0001 |
Heart failure mid-range ejection fraction, n (%) |
10 (2) |
22 (7) |
<0.001 |
Heart failure reduced ejection fraction, n (%) |
12 (2) |
11 (3) |
0.47 |
Other, n (%) |
169 (34) |
169 (50) |
<0.0001 |
Cardiac magnetic resonance imaging data
|
Heart rate (b.p.m.) |
77 ± 14.0 |
74 ± 14 |
0.0004 |
Systolic blood pressure (mmHg) |
146 ± 28 |
140 ± 24 |
<0.001 |
Diastolic blood pressure (mmHg) |
78 ± 12 |
78 ± 14 |
0.32 |
Left ventricular end-diastolic volume (mL) |
103 ± 30 |
121 ± 43 |
<0.0001 |
Left ventricular end-systolic volume (mL) |
32 ± 17 |
45 ± 24 |
<0.0001 |
Left ventricular stroke volume (mL) |
71 ± 22 |
76 ± 27 |
0.001 |
Left ventricular ejection fraction (%) |
69 ± 11 |
63 ± 11 |
<0.0001 |
Left ventricular mass (g) |
84 ± 24 |
118 ± 36 |
<0.0001 |
Left atrial volume (mL) |
75 ± 39 |
82 ± 49 |
0.01 |
Right ventricular end-diastolic volume (mL) |
131 ± 52 |
173 ± 67 |
<0.0001 |
Right ventricular end-systolic volume (mL) |
71 ± 40 |
106 ± 53 |
<0.0001 |
Right ventricular stroke volume (mL) |
60 ± 24 |
67 ± 29 |
<0.001 |
Right ventricular ejection fraction (%) |
47 ± 13 |
40 ± 13 |
<0.0001 |
PCWP assessment
|
Invasive PCWP (mmHg) |
14.0 ± 6.0 |
13.7 ± 6.0 |
0.5 |
Generic CMR-derived PCWP |
13.0 ± 3.0 |
14.7 ± 4.0 |
<0.001 |
Sex-specific CMR-derived PCWP |
14.1 ± 3.0 |
13.8 ± 4.0 |
0.3 |